Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2012
05/29/2012CA2537095C Combinations of a pyrimidine containing nnrti with rt inhibitors
05/29/2012CA2516016C Hepatitis c inhibiting compounds
05/29/2012CA2514584C Peptide inhibitors of toxins derived from ll-37
05/29/2012CA2469623C Composition for the preservation of viruses
05/29/2012CA2455403C Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
05/29/2012CA2442168C N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
05/29/2012CA2441597C Elongated and multiple spacers in activatible prodrugs
05/29/2012CA2417389C Therapeutic polyesters and polyamides
05/29/2012CA2389429C Compositions and methods for counteracting effects of reactive oxygen species and free radicals
05/29/2012CA2379388C Immunoglobulin fusion proteins
05/29/2012CA2361292C A novel chimeric protein for prevention and treatment of hiv infection
05/29/2012CA2338005C Peptide antagonists of zonulin and methods for use of the same
05/29/2012CA2268258C Single-chain multiple antigen-binding molecule, its preparation and use
05/24/2012WO2012068540A2 Neutralizing anti-ccl20 antibodies
05/24/2012WO2012068535A1 Therapeutic compositions comprising rilpivirine hcl and tenofovir disoproxil fumarate
05/24/2012WO2012068470A2 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
05/24/2012WO2012068390A1 INHIBITORS OF FOOT AND MOUTH DISEASE VIRUS TARGETING THE RNA-DEPENDENT POLYMERASE ACTIVITY OF 3Dpol
05/24/2012WO2012068380A2 Methods and compositions for modulating pd1
05/24/2012WO2012068366A2 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
05/24/2012WO2012068234A2 Antiviral compounds
05/24/2012WO2012067978A1 Antibacterial amiinoglycoside analogs
05/24/2012WO2012067866A2 Multivalent vaccine for filariasis
05/24/2012WO2012067138A1 Novel polymer derivative of cytidine metabolism antagonist
05/24/2012WO2012066518A1 2-piperazin-1-yl-4h-1,3-benzothiazin-4-one derivatives and their use for the treatment of mammalian infections
05/24/2012WO2012066442A1 Inhibitors of hiv replication
05/24/2012WO2012066420A1 Lipidated polyepitope vaccines
05/24/2012WO2012066336A1 Benzylamine compounds as toll -like receptor 7 agonists
05/24/2012WO2012066335A1 Phenol compounds als toll -like receptor 7 agonists
05/24/2012WO2012066331A1 Cross protective epitopes of aspergillus fumigatus and candida albicans
05/24/2012WO2012065997A1 Respiratory syncytial virus vaccine
05/24/2012WO2012065963A2 Novel antiviral compounds
05/24/2012WO2012065755A1 Production of ifn-lambda by b cells
05/24/2012WO2012065384A1 Tromantadine compounds with adamantane structure, derivatives and analogs thereof, and their uses as anti-tumor pharmaceuticals
05/24/2012WO2012065263A1 Immunogenic compositions
05/24/2012WO2012065262A1 Expression, purification and refolding of recombinant chlamydia proteins, compositions and related methods
05/24/2012WO2012065201A1 Composition comprising a peptide and an inhibitor of viral neuraminidase
05/24/2012WO2012023008A3 Polysaccharide conjugation with detoxified e. coli heat labile enterotoxin (lt) used as vaccine
05/24/2012WO2012021409A3 Anthraquinone Analogs
05/24/2012WO2012012480A3 Transgenic plants expressing a viral antifungal protein
05/24/2012WO2012009472A3 Structure, synthesis, and applications for oligo phenylene ethynylenes (opes)
05/24/2012WO2011133728A3 Anti-viral compounds
05/24/2012WO2011123668A3 Stereoselective synthesis of phosphorus containing actives
05/24/2012US20120130323 Delivery Product For Topical Compositions
05/24/2012US20120130146 Continuous administration of cilengitide in cancer treatments
05/24/2012US20120129949 Use of Anthracene Derivatives as Anti-Infectives
05/24/2012US20120129948 Medical implant producing wear particles with benign body response
05/24/2012US20120129946 Materials and methods for treating viral infections
05/24/2012US20120129942 Compositions and methods for treating fungal infection of the nail
05/24/2012US20120129935 Nutrition with lipids and non-digestible saccharides
05/24/2012US20120129930 Ketone compounds and compositions for cholesterol management and related uses
05/24/2012US20120129927 New Anthraquinone Derivatives
05/24/2012US20120129917 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq)
05/24/2012US20120129915 Organic compositions to treat hsf1-related diseases
05/24/2012US20120129914 Organic compositions to treat hsf1-related diseases
05/24/2012US20120129913 dsRNA For Treating Viral Infection
05/24/2012US20120129908 Agent For The Prophylaxis And Treatment Of Highly Pathogenic Infectious Diseases
05/24/2012US20120129907 Histidinol dehydrogenase inhibitors, and use thereof as medicaments
05/24/2012US20120129886 Metalloenzyme inhibitor compounds
05/24/2012US20120129878 Tablet
05/24/2012US20120129858 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives
05/24/2012US20120129850 Imidazolothiazole compounds for the treatment of disease
05/24/2012US20120129849 Deuterated serine-threonine protein kinase modulators
05/24/2012US20120129840 Novel viral replication inhibitors
05/24/2012US20120129830 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof
05/24/2012US20120129828 S1p1 receptor agonists and use thereof
05/24/2012US20120129819 Gel compositions for administration of pharmaceutically active compounds
05/24/2012US20120129802 Process for the production of ultrapure galacto-oligosaccharides
05/24/2012US20120129800 Agent For Preventing And Treating Pityriasis Versicolor
05/24/2012US20120129795 Antiviral compounds
05/24/2012US20120129794 Apparati, methods, and compositions for universal microbial diagnosis, detection, quantification, and specimen-targeted therapy
05/24/2012US20120129793 Antimicrobial Polyether and Polyol Compounds
05/24/2012US20120129792 Agent for eliminating multidrug resistance
05/24/2012US20120129776 Bioactive peptides and method of using same
05/24/2012US20120129765 Novel specific hcv ns3 protease inhibitors
05/24/2012US20120129764 Influenza a and b virus replication-inhibiting peptides
05/24/2012US20120129763 Novel semi-synthetic glycopeptides as antibacterial agents
05/24/2012US20120129762 Motilin-like peptide compound having transmucosal absorbability imparted thereto
05/24/2012US20120129761 Preparation of bone cement compositions
05/24/2012US20120129760 Modified peptides with antiviral properties and methods for obtaining them
05/24/2012US20120129263 Recombinant viral vector for gene transfer into lymphoid cells
05/24/2012US20120128787 Homeopathic Composition Comprising Hypericum Perforatum Extract And Essential Oils For The Treatment Of Neuropathic Pain
05/24/2012US20120128782 Multicomponent Degradable Cationic Polymers
05/24/2012US20120128777 Compositions containing lipid micro- or nanoparticles for the enhancement of the dermal action of solid particles
05/24/2012US20120128771 Timed, pulsatile release systems
05/24/2012US20120128763 Lubricant for the ocular surface
05/24/2012US20120128758 Formulation for inducing broadly reactive neutralizing anti-hiv antibodies
05/24/2012US20120128755 Personal Care Composition Containing Yeast Extract And Hexapeptide
05/24/2012US20120128749 Composition and process for production thereof
05/24/2012US20120128729 Gallium Formulation For The Treatment And Prevention of Infectious Diseases
05/24/2012US20120128728 Compositions Comprising Amphotericin B
05/24/2012US20120128720 Mycobacterium mutants for vaccines with improved protective efficacy
05/24/2012US20120128719 Streptococcus vaccine compositions and methods of using the same
05/24/2012US20120128718 Attenuated fnr deficient enterobacteria
05/24/2012US20120128717 Influenza virus vaccine composition and methods of use
05/24/2012US20120128716 Vaccine Compositions
05/24/2012US20120128715 Method for stimulating the immune response of newborns
05/24/2012US20120128712 Vaccine directed against porcine pleuropneumonia and a method to obtain such a vaccine
05/24/2012US20120128710 Enhancement of Pathogen-Specific Memory Th17 Cell Responses
05/24/2012US20120128709 Expression of recombinant proteins
05/24/2012US20120128708 Diagnostic mycobacterium tuberculosis test
1 ... 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 ... 1798